NIGMS funds new stem cell centers

August 09, 2005

Human embryonic stem cells have properties that make them uniquely valuable for studying virtually any cellular process. Despite their promise for research and therapeutic purposes, stem cells are difficult to grow in the laboratory and scientists do not know how to reliably direct them to become a specific cell type.

"If we are to realize the tremendous potential of stem cells, we urgently need more fundamental knowledge about their basic biology and more scientists trained to work with them," said Jeremy M. Berg, Ph.D., director of the National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health (NIH).

To address these needs, NIGMS has funded three new Exploratory Centers for Human Embryonic Stem Cell Research. These centers, which will receive an estimated $9 million over three years, join three others that the institute funded in September 2003. All of the centers are limited to using federally approved stem cell lines listed on the National Institutes of Health Human Embryonic Stem Cell Registry.

"These centers are a crucial step in establishing the infrastructure for scientists to address essential questions about human development and cell differentiation," said Marion M. Zatz, Ph.D., program director for the center grants.

Each center will establish a core facility to support and train scientists and to define the growth conditions and molecular characteristics required for maintaining human embryonic stem cells in an undifferentiated state. Scientists at the centers also will work on specific pilot projects to advance fundamental knowledge of human embryonic stem cell properties and functions.

The new centers are:

  • Mount Sinai School of Medicine in New York City (Gordon Keller, Ph.D., principal investigator)--$965,150 for the first year of funding to study the growth, differentiation and genetic alteration of human embryonic stem cells. The group will focus on developing methods to genetically modify stem cells and will study the molecular signals that cause them to differentiate into red blood cells.

  • Albert Einstein College of Medicine in New York City (Eric Bouhassira, Ph.D., principal investigator)--$965,032 for the first year of funding to study how specific proteins control the growth and differentiation of human embryonic stem cells. The team will also analyze genetic networks and study DNA replication and gene expression in stem cells.

  • The Burnham Institute in La Jolla, California (Evan Snyder, M.D., Ph.D., principal investigator)--$1,060,699 for the first year of funding to study the molecular signals that enable stem cells to self-renew and specialize, develop a novel imaging technology to study the cells in real time, and improve methods for the cells' growth and maintenance. The group will also lead training courses for other scientists.

    In addition to funding the six center grants, NIGMS supports individual grants and grant supplements to advance stem cell research.
    To arrange an interview with Jeremy M. Berg or Marion M. Zatz, contact the NIGMS Office of Communications and Public Liaison at 301-496-7301. More information about NIGMS initiatives related to human embryonic stem cells is available at More information on stem cells in general is available at

    NIGMS ( is one of 27 components of the National Institutes of Health, U.S. Department of Health and Human Services. The NIGMS mission is to support basic biomedical research that lays the foundation for advances in disease diagnosis, treatment, and prevention.

    NIH/National Institute of General Medical Sciences

    Related Stem Cells Articles from Brightsurf:

    SUTD researchers create heart cells from stem cells using 3D printing
    SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

    More selective elimination of leukemia stem cells and blood stem cells
    Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

    Computer simulations visualize how DNA is recognized to convert cells into stem cells
    Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

    First events in stem cells becoming specialized cells needed for organ development
    Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

    Surprising research result: All immature cells can develop into stem cells
    New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

    The development of brain stem cells into new nerve cells and why this can lead to cancer
    Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

    Healthy blood stem cells have as many DNA mutations as leukemic cells
    Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

    New method grows brain cells from stem cells quickly and efficiently
    Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

    NUS researchers confine mature cells to turn them into stem cells
    Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

    Researchers develop a new method for turning skin cells into pluripotent stem cells
    Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

    Read More: Stem Cells News and Stem Cells Current Events
  • is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to